Search

Your search keyword '"Terwindt, Gisela"' showing total 1,187 results

Search Constraints

Start Over You searched for: Author "Terwindt, Gisela" Remove constraint Author: "Terwindt, Gisela"
1,187 results on '"Terwindt, Gisela"'

Search Results

1. Correction: Serum and cerebrospinal fluid neurofilament light chain and glial fibrillary acid protein levels in early and advanced stages of cerebral amyloid angiopathy

3. Serum and cerebrospinal fluid neurofilament light chain and glial fibrillary acid protein levels in early and advanced stages of cerebral amyloid Angiopathy

4. Neuropsychiatric symptoms with focus on apathy and irritability in sporadic and hereditary cerebral amyloid angiopathy

8. Temporal Ordering of Biomarkers in Dutch-Type Hereditary Cerebral Amyloid Angiopathy

12. Medication overuse headache

21. Changes in migraine symptoms after ischemic stroke: a cohort study

23. Genome-wide analysis of 102,084 migraine cases identifies 123 risk loci and subtype-specific risk alleles

26. European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update

28. Genetic Risk Score for Intracranial Aneurysms: Prediction of Subarachnoid Hemorrhage and Role in Clinical Heterogeneity

29. Reply to the letter: Headaches during/after SARS‐CoV‐2 infection/vaccination can be primary and secondary as well as acute and chronic, by Finsterer J and Mehri S

31. Headaches and facial pain attributed to SARS‐CoV‐2 infection and vaccination: a systematic review

34. Diagnosis and management of migraine in ten steps

35. Shared genetic risk between migraine and coronary artery disease: A genome-wide analysis of common variants.

36. Bi-sinusoidal light stimulation reveals an enhanced response power and reduced phase coherence at the visual cortex in migraine

37. Guidelines of the International Headache Society for controlled trials of pharmacological preventive treatment for persistent post-traumatic headache attributed to mild traumatic brain injury

38. Safety considerations in the treatment with anti-CGRP(R) monoclonal antibodies in patients with migraine.

39. EEG Changes in Migraine—Can EEG Help to Monitor Attack Susceptibility?

41. Metabolomics Profile in Depression: A Pooled Analysis of 230 Metabolic Markers in 5283 Cases With Depression and 10,145 Controls

43. Profiling amyloid‐β peptides as diagnostic biomarkers for cerebral amyloid angiopathy

46. Investigating the relationships between unfavourable habitual sleep and metabolomic traits: evidence from multi-cohort multivariable regression and Mendelian randomization analyses

50. Integration of epidemiologic, pharmacologic, genetic and gut microbiome data in a drug–metabolite atlas

Catalog

Books, media, physical & digital resources